Atea Pharmaceuticals, Inc.

AVIR - CIK 0001593899

Market cap-

Rank-

SEC filings301

AVIR income statement (quarterly)

The table below shows Atea Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$41.13M	$38.35M	$32.27M	$29.58M	$26.16M	$34.70M
SG&A

AVIR annual revenue (10-K history)

Atea Pharmaceuticals, Inc. reported annual revenue of $351.37M for fiscal year 2021. That is up 622.5% from $48.63M in fiscal 2020. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.